Used primarily as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure supports the creation of heterocyclic scaffolds found in certain anxiolytic and anticonvulsant drugs. The bromo and fluoro substituents allow for selective cross-coupling reactions, enabling precise molecular modifications during drug optimization. Additionally, its electron-deficient ring system enhances binding affinity in some receptor-targeted therapies. It is also explored in agrochemical research for designing bioactive molecules with improved metabolic stability.